About Preclinical Disease and Prevention
The Preclinical Disease and Prevention unit is devoted to helping people identify and address their risk of developing or managing two of Australia’s most prevalent chronic diseases — cardiovascular disease and diabetes. The research of the Preclinical Disease and Prevention unit is predominantly undertaken in community settings with a focus on higher risk individuals with asymptomatic (no signs or symptoms) disease.
The Preclinical Disease and Prevention unit conducts rigorous, multi-disciplinary clinical trial research to demonstrate the benefits of nurse-facilitated models of care. Integral to this work is the establishment of nurse-led clinics to promote health behaviour change and implement gold standard care to enhance management.
The Unit also develop practical electronic resources for use by individuals and health care professionals that optimise cardiovascular disease management in community and clinical settings.
We collaborate with eminent cardiologists, endocrinologists, leading GP academics and Aboriginal health researchers. These partnerships, combined with the Unit’s expert team of research fellows, clinical researchers, data management and support staff enable the unit to deliver personalised care that targets risk and protective factors to help at risk individuals.
- Multi-site, randomised controlled trials of risk factor management and health and lifestyle interventions for the prevention and management of cardiometabolic disease.
- Establishing the evidence for cost-effective nurse-led clinics and models of care.
- Risk detection and surveillance of traditional and novel risk indicators.
- Atrial fibrillation detection, burden and management.
- Digital eHealth applications for patients living with chronic disease.
- Mass data analyses of primary care management of cardiometabolic risk.
- Pregnancy related cardiovascular disease risk.